πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12084727

Microbiome markers and therapies for autism spectrum disorders

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12083137

Triazole bisphosphonate geranylgeranyl diphosphate synthase inhibitors

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12084403

Linkers for antibody drug conjugates

The Board of Regents of the University of Texas System Β· Granted Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12076328

Pharmaceutical compositions of niclosamide

The Board of Regents of the University of Texas System Β· Granted Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12077563

Prefusion-stabilized hMPV F proteins

The Board of Regents of the University of Texas System Β· Granted Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12077540

Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione

The Board of Regents of the University of Texas System Β· Granted Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12077760

DNA aptamers and use thereof for the treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12077772

Transgene cassettes, AAV vectors and AAV viral vectors for the expression of human codon-o

The Board of Regents of the University of Texas System Β· Granted Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12070443

Methods of treating and preventing breast cancer with S-equol

The Board of Regents of the University of Texas System Β· Granted Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12070444

Modulation of molecular markers using S-equol

The Board of Regents of the University of Texas System Β· Granted Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12070472

Treatment of drug resistant proliferative diseases with telomerase mediated telomere alter

The Board of Regents of the University of Texas System Β· Granted Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12065416

cGAS antagonist compounds

The Board of Regents of the University of Texas System Β· Granted Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12065490

Chimeric antigen receptors and methods of making

The Board of Regents of the University of Texas System Β· Granted Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12064453

Biochemical and biomechanical conditioning for enhancing personalized mesenchymal stem cel

The Board of Regents of the University of Texas System Β· Granted Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12064413

Methods of treating melanoma with S-equol

The Board of Regents of the University of Texas System Β· Granted Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12059474

Methods for selecting antibodies that specifically bind glycosylated immune checkpoint pro

The Board of Regents of the University of Texas System Β· Granted Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12053455

Antigen-driven detection and treatment of coccidioidomycosis

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12054483

Small molecule inhibitors of DYRK/CLK and uses thereof

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12036405

System and method of electric-induced acoustic tomography for electrotherapy monitoring

The Board of Regents of the University of Oklahoma Β· Granted Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12037390

Leptin antibodies and method of reducing leptin

The Board of Regents of the University of Texas System Β· Granted Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12038433

Methods and apparatus for high-throughput screening for testing permeability and retention

The Board of Regents of the University of Texas System Β· Granted Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12036269

Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocystei

The Board of Regents of the University of Texas System Β· Granted Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12036319

Polyvalent sting activating compositions and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12036231

Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

The Board of Regents of the University of Texas System Β· Granted Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted